sb 203580 has been researched along with Inflammatory Bowel Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, J; Jiang, H; Kang, YJ; Omata, M; Otsuka, M; Ren, J; Wang, Y | 1 |
| Di Sabatino, A; Docena, G; Fanning, A; Knowles, CH; Kruidenier, L; Leakey, NA; Lee, K; MacDonald, TT; McLean, PG; Nally, K; Rovedatti, L; Shanahan, F | 1 |
| Hollenbach, E; Malfertheiner, P; Naumann, M; Neumann, M; Roessner, A; Vieth, M | 1 |
| Arimura, Y; Endo, T; Goto, A; Imai, K; Kobayashi, K; Okahara, S; Shinomura, Y | 1 |
| Cabane, C; Colombel, JF; Dérijard, B; Desreumaux, P; Dubuquoy, L; Gay, J; Malamut, G; Malapel, M; Tamboli, C | 1 |
5 other study(ies) available for sb 203580 and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Distinct effects of p38alpha deletion in myeloid lineage and gut epithelia in mouse models of inflammatory bowel disease.
Topics: Amyloid Precursor Protein Secretases; Animals; Cell Differentiation; Cell Proliferation; Imidazoles; Inflammatory Bowel Diseases; Intestinal Mucosa; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinase 14; Myeloid Cells; Organ Specificity; Pyridines | 2010 |
Down-regulation of p38 mitogen-activated protein kinase activation and proinflammatory cytokine production by mitogen-activated protein kinase inhibitors in inflammatory bowel disease.
Topics: Adolescent; Adult; Blotting, Western; Cells, Cultured; Cytokines; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; Female; Humans; Imidazoles; Inflammation Mediators; Inflammatory Bowel Diseases; Interleukin-1beta; Interleukin-6; Intestinal Mucosa; Male; Middle Aged; Niacinamide; Organ Culture Techniques; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Pyrimidines; Tumor Necrosis Factor-alpha; Young Adult | 2010 |
Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease.
Topics: Animals; Colitis, Ulcerative; Cytokines; Disease Models, Animal; Imidazoles; Inflammation Mediators; Inflammatory Bowel Diseases; Mice; Mice, Inbred BALB C; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Plasma Cells; Protein Kinases; Pyridines; Receptor-Interacting Protein Serine-Threonine Kinase 2; Receptor-Interacting Protein Serine-Threonine Kinases; Signal Transduction | 2004 |
Therapeutic implications of the specific inhibition of causative matrix metalloproteinases in experimental colitis induced by dextran sulphate sodium.
Topics: Animals; Colitis; Dextran Sulfate; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Female; Imidazoles; Inflammatory Bowel Diseases; Matrix Metalloproteinase 10; Matrix Metalloproteinase 3; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Metalloendopeptidases; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase Kinases; NF-kappa B; Pyridines; RNA, Small Interfering; Signal Transduction; Tumor Necrosis Factor-alpha | 2006 |
No evidence for an involvement of the p38 and JNK mitogen-activated protein in inflammatory bowel diseases.
Topics: Adult; Animals; Blotting, Western; Colitis, Ulcerative; Disease Models, Animal; Enzyme Inhibitors; Female; Gene Expression; Humans; Imidazoles; Inflammatory Bowel Diseases; Interleukin-1; Intestinal Mucosa; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Inbred BALB C; Middle Aged; p38 Mitogen-Activated Protein Kinases; Polymerase Chain Reaction; Prognosis; Pyridines; RNA, Messenger; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2006 |